ID   LTR228
AC   CVCL_6416
SY   LTR 228; LTR 228-TG; LTR 228 TG
DR   CLO; CLO_0007414
DR   ATCC; HB-8502
DR   Wikidata; Q54903184
RX   Patent=US4624921;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8502.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
ST   Source(s): ATCC=HB-8502
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2761 ! WIL2 NS
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
RX   Patent=US4624921;
RA   Larrick J.W., Raubitschek A.A., Truitt K.E.;
RT   "Human lymphoblastoid cell line and hybridomas derived therefrom.";
RL   Patent number US4624921, 25-Nov-1986.
//